放射性核素细胞凋亡显像

张金山

放射性核素细胞凋亡显像

张金山

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 1: (6-8,25)

引用本文:

Citation:

放射性核素细胞凋亡显像

张金山

510150 广州, 广州市第二人民医院核医学科
中图分类号: R817.4

Apoptosis radionuclide imaging

ZHANG Jin-shan

Department of Nuclear Medicine, Guangzhou Second People's Hospital, Guangzhou 510150, China
CLC number: R817.4

摘要: 放射性核素细胞凋亡显像具有直观、无创伤和实时在体观察细胞凋亡等特点,对于脑、心肌细胞缺血再灌注损伤的观察,器官移植排斥反应的监测,肿瘤放疗和化疗效果的评估等方面的应用前景良好,但仍有许多问题有待于进一步探讨。
- 放射性核素显像 /
- 细胞凋亡 /
- 膜联蛋白V
Abstract: Apoptosis radionuclide imaging is a novel method for the detection of apoptosis, characterised with direct, noninvasive and real-time imaging. It is useful in the observation of brain and myocardial ischemic reperfusion injury, detection of organ graft rejection and evaluation of tumor chemotherapy and radiotherapy effect, but further investigation should be done.
- radionuclide imaging /
- apoptosis /
- annexin V
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Thompson BC. Apoptosis in the pathogensis amd treatment of disease[J]. Science, 1995, 267:1456-1462.
[2]	Blankenberg FG, Katsilis JF, Davis RE, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death[J]. Med Sciences, 1998, 95(11):6349-6354.
[3]	Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis(Programmed Cell Death) with ⁹⁹Tc^m-annexin V[J].J Nucl Med, 1999, 40(1):184-190.
[4]	Narula J, Strauss HW. Implications of Phosphatidyl Serine(PS) reversal in acute ischemic syndromes[J]. J Nucl Med,2003, 44(3):397-399.
[5]	England M, Neiland LJW, Ramaekers FCS, et al. Annexin V-affinnity assay:a review apoptosis detection systom based on phosphatidylserine exposure[J]. Cytometry, 1998, 31(1):1-9.
[6]	Blankenberg FG, Naumovski L, Tait JF, et al. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using ⁹⁹Tc^m-radiolabeled annexin V[J]. J Nucl Med, 2001,42(2):309-316.
[7]	Russell J O, Donoghue JA, Finn R, et al. Iodination of annexin V for imaing apoptosis[J]. J Nucl Med, 2002, 43(5):671-677.
[8]	Vergote J, Benedetto MDI, Moretti JL, et al. Could ⁹⁹Tc^m-MIBI be used to visualize the apoptosis MCF7 human breast cancer cells[J]. Cell Mol Biol, 2001, 47(3):467-471.
[9]	Kemerink GJ, Liem IH, Hofstra L, et al. Patient dosimetry of intravenously administered ⁹⁹Tc^m-annexin V[J]. J Nucl Med,2000, 42(2):382-387.
[10]	Mochizuki T, Kuge Y, Zhao S, et al. Detection of apoptosis tumor response in vivo after a single dose of chemotherapy with ⁹⁹Tc^m-annexin V[J]. J Nucl Med, 2003, 44(1):92-97.
[11]	Ogura Y, Krams SM, Martinez OM, et al. Radiolabeled annexin V imaging:diagnosis of allograft rejection in an experimental rodent model of liver transplantation[J].Radiology, 2000, 214(3):795-800.
[12]	Arceuil HD, Rhine W, de Crespigny A, et al. ⁹⁹Tc^m-annexin V imaging of neonatal hypoxic brain injury[J]. Stroke, 2000,31(11):2692-2698.
[13]	Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction[J].Lancet, 2000, 356(15):209-212.
[14]	Thimister PWL, Hofstra L, Liem IH, et al. In vivo detection of Cell Death in the area at risk in acute myocardial infarction[J]. J Nucl Med, 2003, 44(3):391-396.
[15]	Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection[J]. J Thorac Cardiovasc Surg, 1998, 116(5):844-853.
[16]	Blankenberg FG, Robbins RC, Stoot JH, et al. Radionuclide imaging of acute lung transplant rejection with annexin V[J].Chest, 2000, 117(3):834-840.
[17]	Belhocine T, Steinmetz N, Hustinx R, et al. Increased uptake of the apoptosis-imaging agent ⁹⁹Tc^m recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis[J].Clin Cancer Res, 2002,8(9):2766-2774.
[18]	Yang DJ, Azhdarinia A, Wu P, et al. In vivo and vitro measurement of apoptosis in breast cancer cells using ⁹⁹Tc^m-ECannexin V[J]. Cancer Biother radiopharm, 2001, 16(1):73-78.
[19]	de Wiele CV, Lahorte C, Oyen W, et al. Nuclear medicine imaging to predict response to radiotherapy:areview[J]. Int Radiat Oncol Biol Phys, 2003, 55(1):5-15."[

[1]	安淑娴 , 宋少莉 , 黄钢 . 放射性核素标记的凋亡显像剂的研究进展. 国际放射医学核医学杂志, 2015, 39(6): 470-477. doi: 10.3760/cma.j.issn.1673-4114.2015.06.008
[2]	王荣福 . 细胞凋亡的放射性核素分子功能显像应用进展. 国际放射医学核医学杂志, 2007, 31(4): 201-204.
[3]	段炼 , 李险峰 . 凋亡心肌核素显像的研究进展. 国际放射医学核医学杂志, 2004, 28(1): 9-11.
[4]	尹培 , 边艳珠 . 体内凋亡细胞显像的研究进展. 国际放射医学核医学杂志, 2009, 33(5): 279-282. doi: 10.3760/cnla.j.issn.1673-4114.2009.05.007
[5]	李剑明 , 李亚明 . 新生儿缺氧缺血性脑损伤细胞凋亡及其核素显像实验研究进展. 国际放射医学核医学杂志, 2007, 31(6): 334-336.
[6]	王峰 , 王自正 . 细胞凋亡显像的研究现状及发展前景. 国际放射医学核医学杂志, 2007, 31(1): 1-5.
[7]	陈顺军 , 程兵 . 肿瘤细胞凋亡核素显像分子探针研究进展. 国际放射医学核医学杂志, 2016, 40(2): 149-153. doi: 10.3760/cma.j.issn.1673-4114.2016.02.013
[8]	黄代娟 . 放射性核素标记annexin V凋亡显像在肿瘤研究中的进展. 国际放射医学核医学杂志, 2003, 27(4): 165-167.
[9]	朱小华 . ⁹⁹Tc^m标记annexin V进行体内凋亡显像的研究. 国际放射医学核医学杂志, 2000, 24(2): 51-54.
[10]	张欣 , 李亚明 . ^99mTc标记annexin V类显像剂细胞凋亡显像在肿瘤研究中的应用及进展. 国际放射医学核医学杂志, 2006, 30(4): 210-213.